novo nordisk nvo stock

Novo Nordisk Stock Rises

Shares of Novo Nordisk (NYSE: NVO) were moving higher on Wednesday. The company's stock gained 4.9% as of 1:50 p.m. ET, but gained as much as 5.8% earlier in the day. The leg up comes as the S&P 500 (SNPINDEX: ^GSPC) gained 0.

Benzinga.com · 2d

Novo Nordisk Stock Slides Before Q4 Earnings: Analysts Still See 68% Upside

Novo Nordisk (NVO) reports Q4 earnings with expectations of 86 cents EPS and $11.40B revenues. Stock down 29.55% YOY, 4.81% YTD. Analysts see 68% upside.

Investopedia on MSN · 1d

Novo Nordisk Stock Rises as Q4 Wegovy Sales More Than Double

KEY TAKEAWAYSNovo Nordisk's U.S.-listed shares rose 5% in intraday trading after the Ozempic and Wegovy maker's better-than-estimated quarterly results offset slower 2025 sales growth projections amid "intensifying competition.

Novo Nordisk says it's not immune to potential Trump tariffs

Business Insider · 1d

Novo Nordisk’s (NVO) CEO Is Not Worried About Government Price Negotiations

Novo Nordisk (NVO), a pharmaceutical company, isn’t too worried about the U.S. government’s plan to negotiate prices for its popular diabetes

Bloomberg on MSN · 1d

Novo Nordisk Is Prepared for Trump’s Tariff Threat, CEO Says

Novo Nordisk A/S is prepared for potential tariffs from US President Donald Trump, the Danish drugmaker’s chief executive said, as tensions simmer between Copenhagen and Washington.

Reuters · 1d

Novo Nordisk says it's not immune to potential Trump tariffs, but business is well-positioned

Wegovy maker Novo Nordisk is not immune to tariffs U.S. President Donald Trump is threatening to levy on the European Union, its chief executive said on Wednesday, but it is confident its business is well-positioned.

Novo Nordisk Has Probably Declined Enough

Novo Nordisk's recent decline suggests it may be a Buy again, with strong growth prospects in diabetes and obesity treatments ...

NVO Earnings: Novo Nordisk Jumps on Healthy Sales Beat Driven by Wegovy

American depositary receipts (ADRs) of Novo Nordisk (NVO) jumped over 4% in pre-market trading this morning after reporting a healthy sales ...

Yahoo Finance12d

Is Novo Nordisk (NVO) the Best Stock to Buy and Hold for 2025?

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other ... we used the Finviz stock screener to look for stocks that analysts believe will gain ...

1don MSN

Novo doubles down on next-gen weight loss therapy despite early setback

Novo Nordisk (NVO) stock in focus as company announces new Phase 3 trial for its next-gen weight loss drug CagriSema despite ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results